中文
English| 項目 | 內容 |
|---|---|
| 時間 | 2018-08-18的17:00至19:10 |
| 類型 | 甲類 |
| 積分 | 2 |
| 主辦單位 | 台灣武田藥品工業股份有限公司、中華民國血液病學會 |
| 會議地點 | 板橋凱薩大飯店_宴會樓2樓, 如意 CDE廳 |
(台北場)From clinical trials to real-world practice in multiple myeloma: Proteasome inhibition in the continuous treatment paradigm
107年8月18日(六)17:00:00
武田邀請學會合作舉辦8/17-8/18 MM研討會，有興趣參加者，敬請於8/13前上網登記，謝謝!
Chair’s welcome and introduction
Multiple Myeloma in Taiwan: Where Are We Now and Where Are We Going With the Care of MM Patients?
- Continuous therapy in multiple myeloma: A critical review and current perspectives
- Q&As
- Proteasome inhibition in multiple myeloma therapy: Current evidence and future research
- Q&As
Real-world effectiveness of Ninlaro: local case sharing
Panel discussion
Summary and close
Chair’s welcome and introduction
Multiple Myeloma in Taiwan: Where Are We Now and Where Are We Going With the Care of MM Patients?
- Continuous therapy in multiple myeloma: A critical review and current perspectives
- Q&As
- Proteasome inhibition in multiple myeloma therapy: Current evidence and future research
- Q&As
Real-world effectiveness of Ninlaro: local case sharing
Panel discussion
Summary and close